Tuesday, November 17, 2026

Czech Republic Moves Toward Legal Medical Use of Psilocybin

Share

The Czech Republic is on the verge of becoming one of the first European countries to legalize the medical use of psilocybin, an active compound found in psychedelic mushrooms. A new amendment passed by the lower house of parliament would permit the use of psilocybin in clinical settings under the supervision of licensed psychiatrists and therapists.

This proposal is part of a broader set of criminal code reforms aimed at modernizing drug laws and improving access to mental health care. The bill is now with the Senate, where it is expected to pass without significant opposition.

Why Psilocybin?

Psilocybin is currently only available in Czech clinical trials. Still, research has shown potential benefits for individuals with depression, especially those who haven’t responded to standard antidepressants. According to local media, the ongoing shortage of certain medications like Anafranil has pushed some patients to look for alternative solutions, including psychedelics.

The National Institute of Mental Health has been closely involved in this research. Experts there suggest that psychedelics could provide relief when conventional treatments fall short, potentially reducing patient suffering more rapidly and effectively.

Public and Political Support

Public backing appears strong. A recent survey indicates that 68% of Czech citizens support the medical use of psychedelics, provided they are prescribed by healthcare professionals. This growing acceptance mirrors the shifting political climate around psychedelic therapies.

European Context

While several European countries have decriminalized psychedelic substances, such as Portugal and the Netherlands, few have taken legal steps to permit medical use. Germany and the UK have only recently begun limited clinical trials.

Despite the excitement around psychedelic-assisted therapy, researchers continue to urge caution. A review of existing studies suggests that many show only short-term improvements rather than lasting cures. Experts warn that while the treatment can be promising, it should not be seen as a universal solution for mental health disorders.

Read more

Local News